In March this year, a ScienceDaily article reported that Mass General is pioneering a Phase 1 clinical trial advancing stem cell therapies for Parkinson's disease. The trial involves reprogramming patients' own stem...
Phase III exPDite-2 trial follows completion and discussion of Phase I trial data with US FDA under Regenerative Medicine Advanced Therapy (RMAT) designation exPDite-2 is a randomized, sham surgery-controlled double-blind trial assessing...
Link to study, found in the journal named Reports, dated 2024. The problem? Neuropathy of the lower leg caused by tarsal tunnel syndrome Symptoms include Sharp shooting pain Pins/needles Electric shock/burning sensations...